CURRENT TESTING IS INACCURATE
Current Alzheimer’s disease testing technologies – such as imaging and spinal fluid taps – are inaccurate, invasive, costly, and often frightening to the patient.
EXCESSIVE DOCTOR VISITS
In early stages of Alzheimer’s disease, patients make an estimated 5 or more doctor visits, with inaccurate testing and no certainty of diagnosis.
MISDIAGNOSIS RUNS RAMPANT
An estimated 1/3 of people exhibiting dementia symptoms do not have Alzheimer’s disease, yet are improperly treated and medicated as if they do.
Numerous medical studies and reports evidence that the mere presence of plaque or tau tangles does not correspond to a diagnosis of Alzheimer’s Disease.
The result is many people fail to get the proper treatment for the true cause of their dementia.
INCREASING EARLY DETECTION AND DIAGNOSIS OF ALZHEIMER’S DISEASE RESULTS IN MASSIVE COST SAVINGS
According to the Alzheimer’s Disease Association 2018 ALZHEIMER’S DISEASE FACTS AND FIGURES Special Report, published this year, early detection and diagnosis would result in the savings of billions of dollars in healthcare costs.